Skip to content

Search

Showing results for " buy cvv2, 【 Visit Amsiga.com 】 ojM3t2s., cc shop carding, gift card no vbv, www validcc UNt2"

Back to school anxiety: How to help your child transition into the new school year

As we count down to the end of the long summer holidays, it’s natural for children to feel anxious about what the new school year will bring.

Starting school, coping with change - Monique Robinson

The beginning of a new school year is just around the corner – and with this may come a big change in your and your child’s life.

PAEDS - Paediatric Active Enhanced Surveillance

The PAEDS Study monitors childhood conditions of public health importance that are difficult to effectively capture through other surveillance mechanisms.

Ahead of consensus: A paediatric antifungal prophylaxis census

To contextualise the ‘Australian & New Zealand Antifungal Consensus Guidelines, 2014, researchers surveyed current routine primary antifungal prophylaxis.

Preparing for Your Kids Check Appointment

Find information about ORIGINS Kids Checks, what you need to do before your appointment, and other questionnaire timepoints.

Your impact

Ever wondered just what your gift means to us? Here's a snapshot.

Western oropharyngeal and gut microbial profiles are associated with allergic conditions in Chinese immigrant children

Distinct differences in microbiome compositions were found in both oropharyngeal and fecal samples of Australian Chinese and Chinese-born Chinese children

Birth cohorts in asthma and allergic diseases: Report of a NIAID/NHLBI/MeDALL joint workshop

Population-based birth cohorts on asthma and allergies increasingly provide new insights into the development and natural history of the diseases.

About us

The Health Promotion and Education Research Team at The Kids Research Institute Australia received funding from the auDA Foundation to develop this

Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy

Platinum-based chemotherapy in combination with anti-PD-L1 antibodies has shown promising results in mesothelioma. However, the immunological mechanisms underlying its efficacy are not well understood and there are no predictive biomarkers to guide treatment decisions.